Biosimilars: An Approach to some Current Worldwide Regulation Frameworks (original) (raw)
Related papers
REGULATORY CONSIDERATIONS OF BIOSIMILARS AND CLINICAL DILEMA OF THEIR USE
Biosimilars: Regulatory Status and Implications across the World
Journal of Pharmacovigilance, 2016
Regulatory challenges with biosimilars: an update from 20 countries
Annals of the New York Academy of Sciences, 2020
REFERENCE BIOLOGICAL MEDICINES ('ORIGINATORS') AND 'BIOSIMILARS': COMPETITION AND PATIENT PROTECTION
Global regulatory landscape of biosimilars: emerging and established market perspectives
Biosimilars, 2015
Clinical Therapeutics, 2012
Comparing Originator Biologics and Biosimilars: A Review of the Relevant Issues
Clinical Therapeutics, 2017
International Journal of Pharmacy and Pharmaceutical Sciences, 2016
Biosimilars in the European market
GaBI Journal, 2013
PANLAR consensus statement on biosimilars
Clinical Rheumatology, 2019
Biosimilars in Developed Economies: Overview, Status, and Regulatory Considerations
Regulatory Toxicology and Pharmacology, 2019
REVIEW ARTICLE Biosimilars for Healthcare Professionals
Generics and Biosimilars Initiative Journal, 2016
Biosimilars and the Patent Law
Medicine, Law & Society, 2019
2010
Biosimilars: from Technical to Pharmacoeconomic Considerations
Jean-louis Montastruc, Marta Gersberg
Thérapie, 2015
The regulatory landscape of biosimilars: WHO efforts and progress made from 2009 to 2019
Biologicals, 2020
Biosimilars for Healthcare Professionals
Biosimilars: Overview of current legislation and future prospects
JPR Solutions, Rishi Kant Pandey
Biosimilar medical products – licensing, pharmacovigilance and interchangeability
PRILOZI, 2016
The regulatory framework of biosimilars in the European Union
Drug Discovery Today, 2012
Recommendations for the regulation of biosimilars and their implementation in Latin America
Generics and Biosimilars Initiative Journal, 2014
Practical Guidance on Biosimilars, With a Focus on Latin America
Current Status of Biosimilar Regulations in the MENA Region
International Journal of Research in Pharmaceutical Sciences, 2020
Market access of biosimilars: not only a cost issue
Oncologie, 2011
The Science Behind Biosimilars: Entering a New Era of Biologic Therapy
Arthritis & rheumatology (Hoboken, N.J.), 2018
Review, Approval, and Marketing of Biosimilars in the United States
BioProcess International, 2010
Biosimilars regulation in United States and FDA approved biosimilars from 2015-2018
Applied Clinical Research, Clinical Trials and Regulatory Affairs, 2019
Biologicals and biosimilars: safety issues in Europe
Expert opinion on biological therapy, 2017